 |
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label randomised trial
Dondorp, Arjen M., Fanello, Caterina, Hendriksen, Ilse, Gomes, Ermelinda, Seni, Amir, Chhaganlal, Kajal D., Bojang, Kalifa, Olaosebikan, Rasaq, Anunobi, Nkechinyere, Maitland, Kathryn, Kivaya, Esther, Agbenyega, Tsiri, Nguah, Samuel Blay, Evans, Jennifer, Gesase, Samwel, Kahabuka, Catherine, Mtove, George, Nadjm, Behzad, Deen, Jacqueline L., Mwanga-Amumpaire, Juliet, Nansumba, Margaret, Karema, Corine, Umulisa, Noella, Uwimana, Aline, Mokuolu, Olugbenga A, Adedoyin, Olanrewaju T, Johnson, Wahab B. R., Tshefu, Antoinette K., Onyamboko, Marie A., Sakulthaew, Tharisara, Ngum, Wirichada Pan, Silamut, Kamolrat, Stepniewska, Kasia, Woodrow, Charles, Day, Nicholas P. J., White, Nicholas J., Wills, Bridget, Oneko, Martina, Bethell, Delia, Petro, Tim E. and von Seidlein, Lorenz (2010). Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label randomised trial. The Lancet,376(9753):1647-1657.
|
|
|
Document type:
|
Journal Article
|
| |
|
|
|
| Access Statistics: |
201 Abstract Views -
Detailed Statistics
|
| Created: |
Fri, 17 Jan 2014, 00:36:08 CST
|
|
|
|
|